News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
23,981 Results
Type
Article (911)
Press Release (23070)
Section
Business (12740)
Career Advice (52)
Deals (1603)
Drug Delivery (1)
Drug Development (2097)
FDA (363)
Job Trends (605)
News (16000)
Policy (684)
Tag
Academia (42)
Accelerated approval (1)
Allergies (1)
Alliances (699)
ALS (3)
Alzheimer's disease (33)
Antibody-drug conjugate (ADC) (4)
Approvals (378)
Artificial intelligence (1)
Bankruptcy (3)
Best Places to Work (556)
Biosimilars (2)
Biotechnology (1)
Bladder cancer (1)
Breast cancer (16)
Cancer (73)
Cardiovascular disease (4)
Career advice (37)
CAR-T (1)
Cell therapy (7)
Clinical research (1823)
Collaboration (6)
Compensation (16)
COVID-19 (41)
CRISPR (1)
C-suite (1)
Cystic fibrosis (1)
Data (92)
Depression (2)
Diabetes (8)
Diagnostics (224)
Drug discovery (2)
Duchenne muscular dystrophy (1)
Earnings (12078)
Events (2432)
Executive appointments (2)
FDA (443)
Friedreich's ataxia (1)
Frontotemporal dementia (1)
Funding (12)
Gene editing (1)
Gene therapy (8)
GLP-1 (19)
Government (91)
Guidances (41)
Healthcare (661)
IgA nephropathy (1)
Immunology and inflammation (2)
Infectious disease (46)
Inflammatory bowel disease (6)
Intellectual property (1)
Interviews (4)
IPO (1301)
Job creations (87)
Job search strategy (36)
Layoffs (11)
Legal (130)
Liver cancer (4)
Lung cancer (10)
Lymphoma (5)
MASH (3)
Medical device (660)
Medtech (660)
Mergers & acquisitions (321)
Metabolic disorders (16)
Multiple sclerosis (4)
NASH (1)
Neurodegenerative disease (3)
Neuropsychiatric disorders (2)
Neuroscience (48)
NextGen: Class of 2025 (136)
Non-profit (112)
Obesity (4)
Opinion (4)
Ovarian cancer (1)
Parkinson's disease (4)
Patents (1)
Peanut (1)
People (524)
Phase I (408)
Phase II (712)
Phase III (802)
Pipeline (201)
Postmarket research (105)
Preclinical (155)
Prostate cancer (5)
Psychedelics (1)
Radiopharmaceuticals (5)
Rare diseases (7)
Real estate (78)
Regulatory (518)
Reports (4)
Research institute (36)
Resumes & cover letters (14)
RSV (3)
Schizophrenia (4)
Series A (1)
Series B (1)
Sickle cell disease (1)
Spinal muscular atrophy (3)
Startups (48)
Vaccines (4)
Weight loss (1)
Date
Today (31)
Last 7 days (99)
Last 30 days (183)
Last 365 days (1503)
2025 (556)
2024 (1655)
2023 (1814)
2022 (2059)
2021 (2078)
2020 (1823)
2019 (1372)
2018 (1070)
2017 (792)
2016 (440)
2015 (674)
2014 (577)
2013 (286)
2012 (351)
2011 (5655)
2010 (463)
Location
Africa (19)
Alabama (1)
Arizona (3)
Asia (1440)
Australia (141)
California (318)
Canada (70)
China (21)
Colorado (17)
Connecticut (18)
Delaware (10)
Europe (2984)
Florida (39)
Georgia (6)
Illinois (30)
India (2)
Indiana (21)
Japan (6)
Kansas (2)
Louisiana (2)
Maine (5)
Maryland (34)
Massachusetts (184)
Michigan (12)
Minnesota (25)
Missouri (5)
Montana (3)
Nevada (2)
New Hampshire (7)
New Jersey (102)
New York (83)
North Carolina (46)
Northern California (167)
Ohio (5)
Pennsylvania (71)
South America (32)
Southern California (116)
Tennessee (1)
Texas (24)
United States (1122)
Utah (19)
Virginia (10)
Washington D.C. (1)
Washington State (33)
Wisconsin (3)
23,981 Results for "132".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Click Therapeutics Announces FDA Marketing Authorization for CT-132, the First Prescription Digital Therapeutic for the Preventive Treatment of Episodic Migraine in the United States
April 15, 2025
·
10 min read
Prostate cancer
AstraZeneca’s Truqap Posts Another Pivotal Disappointment as Phase III Prostate Cancer Study Fails
The drug, a small molecule protein inhibitor, brought in $132 million in the first quarter, missing consensus estimates by 17%.
April 30, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Oral Biologics Market Size to Hit USD 132.6 Billion by 2030, Coherent Market Insights
January 9, 2025
·
1 min read
Press Releases
In Vitro Diagnostics Market Size to Attain USD 132.18 Bn by 2034
December 17, 2024
·
14 min read
Biotech Beach
Endeavor BioMedicines Raises $132.5 Million Oversubscribed Series C Financing to Advance Pipeline of Transformational Medicines
Endeavor BioMedicines, Inc. today announced the closing of a $132.5 million Series C financing, including the conversion of a $5 million convertible instrument.
April 24, 2024
·
4 min read
Biotech Beach
Alterome Therapeutics Raises $132 Million in Series B Financing Led by Goldman Sachs Alternatives
Alterome Therapeutics, Inc., a biopharmaceutical company pioneering the development of next generation, small molecule targeted therapies for the treatment of cancer, announced the closing of a $132 million Series B financing.
April 3, 2024
·
4 min read
Press Releases
Cell And Gene Therapy Market Size to Hit US$ 132.6 Billion by 2030, Coherent Market Insights
November 8, 2024
·
1 min read
Press Releases
Akeso Published Mechanism of Action for CLDN18.2/CD47 Bispecific Antibody AK132 for the First Time at SITC Annual Meeting
November 7, 2024
·
5 min read
Press Releases
Diabetes Drug Market Size to Attain Around USD 132.36 Billion by 2034
July 29, 2024
·
9 min read
Press Releases
Biotechnology Instruments Market Size to Touch USD 132.80 Billion by 2033
July 16, 2024
·
14 min read
1 of 2,399
Next
